LAT1 (SLC7A5) Overexpression in Negative Her2 Group of Breast Cancer: A Potential Therapy Target

OBJECTIVE: HER2 negative carcinomas of the breast pose a challenge for treatment due to redundancies in potential drug targets and poor patient outcomes. Our aim was to investigate the role of L-type amino acid transporter – LAT1 as a potential prognosticator and a drug target. METHODS: In this retr...

Descripción completa

Detalles Bibliográficos
Autores principales: Bodoor, Khaldon, Almomani, Rowida, Alqudah, Mohammad, Haddad, Yazan, Samouri, Walaa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541863/
https://www.ncbi.nlm.nih.gov/pubmed/32458655
http://dx.doi.org/10.31557/APJCP.2020.21.5.1453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541863/
https://www.ncbi.nlm.nih.gov/pubmed/32458655
http://dx.doi.org/10.31557/APJCP.2020.21.5.1453

Ejemplares similares